UPDATE: Goldman Sachs Assumes Arcturus Therapeutics (ARCT) at Neutral
Tweet Send to a Friend
(Updated - June 25, 2021 3:05 AM EDT)
Goldman Sachs analyst Madhu Kumar assumes coverage on Arcturus Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Madhu Kumar assumes coverage on Arcturus Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
